Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy
- 241 Downloads
Single chemotherapeutic agent like paclitaxel (PTX) has shown some limitations in anti-tumor treatment, such as undesirable side effects, multidrug resistance, and high toxicity. In order to reduce the toxicity of PTX and increase the anti-tumor effect, folate-modified amphiphilic and biodegradable biomaterial was developed to co-deliver PTX and metformin (MET) for exerting the synergistic effect. PTX was physically entrapped in the hydrophobic inner core of the amphiphilic block copolymer by a solvent evaporation method, whereas MET was chemically conjugated to the hydrophilic terminals of copolymer via a pH-sensitive cis-aconityl linkage (Cis). The in vitro release behaviors of the drugs were analyzed by high-performance liquid chromatography (HPLC), and the synergistic effect of the drugs was evaluated by a Q value method. Results showed that drug-loaded micelles with an average size about 100 nm were successfully constructed. In acidic environments, the chemically conjugated MET was rapidly released after the breakage of sensitive bond between drug and copolymer. In vitro anti-tumor studies demonstrated that MET and PTX had a synergistic effect and co-delivery micelles induced higher cytotoxicity and apoptosis against 4T1 breast cancer cells than free drugs. Furthermore, folate-targeted co-delivery micelles increased the cellular uptake of drugs and were found to be effective for the treatment of solid tumor in vivo. These findings indicated that co-delivery of MET and PTX through the polymeric micelles is a promising strategy for cancer therapy.
KEY WORDSmetformin paclitaxel polymeric micelles folic acid pH-sensitive
We are thankful to the Key Laboratory of Drug Targeting and Drug Delivery Systems for providing the 4T1 cell and the near-infrared fluorescence dye, DiD.
This research was financially supported by the National Natural Science Foundation of China (No. 81673363).
- 2.Bodmer M, Becker C, Meier C, Jick SS, Meier CR. Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecol Oncol. 2011;123(2). https://doi.org/10.1016/j.ygyno.2011.06.03.
- 6.Hanna RK, Zhou C, Malloy KM, Sun L, Zhong Y, Gehrig PA, et al. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway. Gynecol Oncol. 2012;125(2):458–69. https://doi.org/10.1016/j.ygyno.2012.01.009.CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Jin T, Li TJ, Wu T. Antitumor machanism and toxicology of paclitaxel. J Northeast Agric Univ. 2005;36(6):816–9.Google Scholar
- 9.Wang H, Zhao Y, Wu Y, Hu YL, Nan K, Nie G, et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG–PLGA copolymer nanoparticles. Biomaterials. 2011;32(32):8281–90. https://doi.org/10.1016/j.biomaterials.2011.07.032.CrossRefPubMedGoogle Scholar
- 25.Kumar A, Balakrishna T, Rajiv J, et al. Formulation and evaluation of mucoadhesive microcapsules of metformin HCl with gum karaya. Int J Pharm Pharm Sci. 2011;3:150–5.Google Scholar
- 31.Zhao X, Chen Q, Li Y, Tang H, Liu W, Yang X. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur J Pharm Biopharm. 2015;93:27–36. https://doi.org/10.1016/j.ejpb.2015.03.003.CrossRefPubMedGoogle Scholar
- 33.Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. Biomaterials. 2009;30(16):3009–19. https://doi.org/10.1016/j.biomaterials.2009.02.011.CrossRefPubMedGoogle Scholar
- 34.Zheng Y, Song XR, Darby M, Liang Y, He L, Cai Z, et al. Preparation and characterization of folate-poly (ethylene glycol)-grafted-trimethylchitosan for intracellular transport of protein through folate receptor-mediated endocytosis. J Biotechnol. 2010;145(1):47–53. https://doi.org/10.1016/j.jbiotec.2009.09.007.CrossRefPubMedGoogle Scholar
- 35.Shmeeda H, Amitay Y, Gorin J, Tzemach D, Mak L, Ogorka J, et al. Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells. J Control Release. 2010;146(1):76–83. https://doi.org/10.1016/j.jconrel.2010.04.028.CrossRefPubMedGoogle Scholar
- 40.Yang Z, Sun N, Cheng R, Zhao C, Liu Z, Li X, et al. pH multistage responsive micellar system with charge-switch and PEGlayer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells. Biomaterials. 2017;147:53–67. https://doi.org/10.1016/j.biomaterials.2017.09.013.CrossRefPubMedGoogle Scholar
- 44.Ke XY, Ng V, Gao SJ, et al. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials. 2014;35(3):1096–108. https://doi.org/10.1016/j.biomaterials.2013.10.049.CrossRefPubMedGoogle Scholar